Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Life Science Alliance|August 21, 2023
Tumor necrosis factor mediates USE1-independent FAT10ylation under inflammatory conditionsLeonie Schnell, Alina Zubrod, Nicola Catone, et al.Molecular Immunology|February 26, 2008
Modulation of murine complement receptor type 2 (CR2/CD21) ectodomain shedding by its cytoplasmic domainMelanie M Hoefer, Annette Aichem, Andrew M Knight, et al.Methods in Enzymology|March 10, 2019
Analysis of modification and proteolytic targeting by the ubiquitin-like modifier FAT10Annette Aichem, Annika N Boehm, Nicola Catone, et al.Nature Communications|March 22, 2012
FAT10 and NUB1L bind to the VWA domain of Rpn10 and Rpn1 to enable proteasome-mediated proteolysisNeha Rani, Annette Aichem, Gunter Schmidtke, et al.The Journal of Biological Chemistry|February 6, 2019
The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1Johanna Bialas, Annika N Boehm, Nicola Catone, et al.Biomedicines|January 8, 2025
Phosphorylated FAT10 Is More Efficiently Conjugated to Substrates, Does Not Bind to NUB1L, and Does Not Alter Degradation by the ProteasomeJinjing Cao, Annette Aichem, Michael Basler, et al.Journal of Cell Science|October 2, 2014
The ubiquitin-like modifier FAT10 decorates autophagy-targeted Salmonella and contributes to Salmonella resistance in miceValentina Spinnenhirn, Hesso Farhan, Michael Basler, et al.Frontiers in Immunology|August 18, 2025
The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentationNatalie Pach, Sarah Ochs, Jinjing Cao, et al.Cell Reports|March 17, 2021
Parkin is an E3 ligase for the ubiquitin-like modifier FAT10, which inhibits Parkin activation and mitophagyNicola D Roverato, Carolin Sailer, Nicola Catone, et al.Immunogenetics|March 7, 2018
The expression profile of the ubiquitin-like modifier FAT10 in immune cells suggests cell type-specific functionsRichard Schregle, Mei Min Mah, Stefanie Mueller, et al.Pageof 4